Comparing effects of interleukin-2 and interleukin-4 on the expression of MHC class II, CD80 and CD86 on polymorphonuclear neutrophils

Egyptian Journal of Medical Human Genetics

Volumn 11, Issue 2, 2010, Pages 115-120

  Abdel Salam, Bahaa Kenawy Abuel Hussien ^a  

^a Minia University ^*  (Egypt)

Author keywords

CD80; CD86; IL 2; IL 4; MHC class II; PMN

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT INTERLEUKIN 2;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUTROPHIL; NORMAL HUMAN; T LYMPHOCYTE ACTIVATION;

EID: 84900375750     PISSN: 11108630     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmhg.2010.05.002     Document Type: Article

References (36)

1. 4A and adenosine triphosphate interact with granulocyte-macrophage colony-stimulating factor to delay neutrophil apoptosis: implications for neutrophil-platelet interactions during inflammation. Blood 1996;87:3442-9.
2. Stringer RE, Hart CA, Edwards SW. Sodium butyrate delays neutrophil apoptosis: role of protein biosynthesis in neutrophil survival. Brit J Hematol 1996;92:169-75.
3. Shen L, Guyre PM, Fanger MW. Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG. J Immunol 1987;139:534-8.
4. Petroni KC, Shen L, Guyre PM. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptormediated functions by IFN-and glucocorticoids. J Immunol 1988;140:3467-72.
5. Lloyd AR, Oppenheim JJ. Poly's lament, the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol Today 1992;13:169-72.
6. Iking-konert C, Wagner C, Denefleh B, Hug F, Schneider M, Andrassy K, et al.. Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease. Clin Exp Immunol 2002;130:501-8.
7. Vachiery N, Totte P, Balcer V, Martinez D, Bensaid A. Effect of isolation techniques, in vitro culture and IFN-γ treatment on the constitutive expression of MHC class I and class II molecules on goat neutrophils. Vet Immunol Immunopath 1999;70:19-32.
8. Radsak M, Iking-koner C, Stegmaie S, Andrass K, Hänsch GM. Polymorphonuclear neutrophils as accessory cells for T-cell activation: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation. Immunology 2000;101:521-30.
9. Iking-Konert C, Vogt S, Radsak M, Wagner C, Hänsch GM, Andrassy K. Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells. Kidney Int 2001;60:2247-62.
10. Tyler AW, Terry KB, Lorne AB, Philip JG. Bovine polymorphonuclear cells passively acquire membrane lipids and integral membrane proteins from apoptotic and necrotic cells. J Leuko Biol 2006;79:1226-33.
11. Shauna C, Owain RM, James MB, Iain BM. Murine neutrophils present class II restricted antigen. Immunol Lett 2008;118:49-54.
12. Steinbeck MJ, Roth JA. Neutrophil activation by recombinant cytokines. Rev Infect Dis 1989;11:549-68.
13. Bahaa KA, Hossam E. Up-regulation of major histocompatibility complex class II, CD83, CD64 and CD14 on polymorphonuclear neutrophils stimulated with interleukin-15. J Microbiol Immunol Infect 2008;41:462-8.
14. Waldmann TA. The multi-subunit interleukin-2 receptor. Ann Rev Biochem 1989;58:875-905.
15. Espinoza-Delgado I, Longo DL, Gusella CL, Varesio L. IL-2 enhances c-fms expression in human monocytes. J Immunol 1990;145:1137-43.
16. Djeu JY, Liu JH, Wie S, Rui H, Pearson CA, Leonard WJ, et al.. Function associated with IL-2 receptor β on human neutrophils: mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 1993;150:960-70.
17. Holter W. Interleukin-4: structure and function. In: Remick DG, Friedland JS, editors. Cytokines in health and disease. New York, NY: Marcel Dekker; 1997. p. 53.
18. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 1991;77:1859-70.
19. Idzerda RL, March CJ, Mosley B, Lyman SD, Vanden BT, Gimpel SD, et al.. Human interleukin-4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990;171:861-73.
20. Aversa G, Punnonen J, Cocks BG, Malefyt Jr FV RW, Zurawski SM, Zurawski G, et al.. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 and IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 1993;178:2213-8.
21. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol 1997;61:375-80.
22. Newburger PE, Subrahmanyam BK, Weissman SM. Global analysis of neutrophil gene expression. Curr Opin Hematol 2000;7:16-20.
23. Colotta F, Re F, Polentarutti N, Sozanni S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992;80:2012-20.
24. Klebanoff SJ, Olszowski S, van Voorhis WC, Ledbetter JA, Waltersdorph AM, Schlechte KG. Effects of gamma interferon on human neutrophils, protection from deterioration on storage. Blood 1992;80:225-34.
25. Lee A, Whyte MB, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 1993;54:283-8.
26. Biffl WL, Moore EE, Moore FA, Barnett CC, Carl VS, Peterson VM. Interleukin-6 delays neutrophil apoptosis. Arch Surg 1996;131:24-30.
27. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, et al.. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T-cell proliferation, cytokine production, and generation of CTL. J Immunol 1995;154:97-105.
28. Reinisch W, Tillinger W, Lichtenberger C, Gangl A, Willheim M, Scheiner O, et al.. In vivo induction of HLA-DR on human neutrophils in patients treated with interferon-γ. Blood 1996;87: 3067-8.
29. Gosselin EJ, Wardwell K, Rigby WF, Guyre PM. Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colonystimulating factor, IFN-gamma, and IL-3. J Immunol 1993;151:1482-90.
30. Mudzinski SP, Christian TP, Guo E, Cirenza E, Hazlett KR, Gosselin EJ. Expression of HLA-DR (major histocompatibility complex class II) on neutrophils from patients treated with granulocyte-macrophage colony-stimulating factor for mobilization of stem cells. Blood 1995;86:2452-3.
31. Smith WB, Guida L, Sun Q, Korpelainen EL, van de huevel G, Gillis D, Hawrylowicz CM, Vadas MA, Lopez AF. Neutrophils activation by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression. Blood 1995;86:3938-44.
32. Djeu JY, Matshushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 1990;144:2205-10.
33. Bahaa KA. T-cells proliferation by stimulated polymorphonuclear neutrophils in presence of superantigen. Assuit Uni J Zool 2009;1:143-58.
34. Liu JH, Wei S, Ussery D, Epling-Burnette PK, Leonard WJ, Djeu JY. Expression of interleukin-2 receptor gamma chain on human neutrophils. Blood 1994;84:3870-5.
35. Wang HY, Paul WE, Keegan AD. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor α chain. Immunity 1996;4:113-21.
36. Janeway CA, Travers P, Walport M, Shlomchik MJ. Immunobiology. 5th ed. New York, USA: Garland Publishing; 2001, p. 732.